105 related articles for article (PubMed ID: 20460511)
1. Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells.
Cammareri P; Scopelliti A; Todaro M; Eterno V; Francescangeli F; Moyer MP; Agrusa A; Dieli F; Zeuner A; Stassi G
Cancer Res; 2010 Jun; 70(11):4655-65. PubMed ID: 20460511
[TBL] [Abstract][Full Text] [Related]
2. ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance.
Tsoumas D; Nikou S; Giannopoulou E; Champeris Tsaniras S; Sirinian C; Maroulis I; Taraviras S; Zolota V; Kalofonos HP; Bravou V
Cancer Genomics Proteomics; 2018; 15(2):127-141. PubMed ID: 29496692
[TBL] [Abstract][Full Text] [Related]
3. Stem cells and colorectal carcinogenesis.
Stoian M; Stoica V; Radulian G
J Med Life; 2016; 9(1):6-11. PubMed ID: 27713769
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity of Glioma stem cells to Aurora kinase A inhibitors: implications for stem cell mitosis and centrosome dynamics.
Mannino M; Gomez-Roman N; Hochegger H; Chalmers AJ
Stem Cell Res; 2014 Jul; 13(1):135-43. PubMed ID: 24879067
[TBL] [Abstract][Full Text] [Related]
5. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.
D'Assoro AB; Liu T; Quatraro C; Amato A; Opyrchal M; Leontovich A; Ikeda Y; Ohmine S; Lingle W; Suman V; Ecsedy J; Iankov I; Di Leonardo A; Ayers-Inglers J; Degnim A; Billadeau D; McCubrey J; Ingle J; Salisbury JL; Galanis E
Oncogene; 2014 Jan; 33(5):599-610. PubMed ID: 23334326
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers.
Tolue Ghasaban F; Maharati A; Zangouei AS; Zangooie A; Moghbeli M
Cancer Cell Int; 2023 Aug; 23(1):170. PubMed ID: 37587481
[TBL] [Abstract][Full Text] [Related]
7. Emerging roles of Aurora-A kinase in cancer therapy resistance.
Zheng D; Li J; Yan H; Zhang G; Li W; Chu E; Wei N
Acta Pharm Sin B; 2023 Jul; 13(7):2826-2843. PubMed ID: 37521867
[TBL] [Abstract][Full Text] [Related]
8. Copy Number Variations as Determinants of Colorectal Tumor Progression in Liquid Biopsies.
Debattista J; Grech L; Scerri C; Grech G
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675253
[TBL] [Abstract][Full Text] [Related]
9. Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment.
Kilmister EJ; Koh SP; Weth FR; Gray C; Tan ST
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428556
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms on chemotherapy resistance of colorectal cancer stem cells and research progress of reverse transformation: A mini-review.
Chen L; Yang F; Chen S; Tai J
Front Med (Lausanne); 2022; 9():995882. PubMed ID: 36172536
[TBL] [Abstract][Full Text] [Related]
11. The role of gut microbiota in the development of colorectal cancer: a review.
Koyande N; Gangopadhyay M; Thatikonda S; Rengan AK
Int J Colorectal Dis; 2022 Jul; 37(7):1509-1523. PubMed ID: 35704091
[TBL] [Abstract][Full Text] [Related]
12. The Relevance of Aurora Kinase Inhibition in Hematological Malignancies.
Machado CB; DA Silva EL; Dias Nogueira BM; DA Silva JBS; DE Moraes Filho MO; Montenegro RC; DE Moraes MEA; Moreira-Nunes CA
Cancer Diagn Progn; 2021; 1(3):111-126. PubMed ID: 35399305
[TBL] [Abstract][Full Text] [Related]
13. Targeting AURKA by microRNA-490-3p suppresses gastric cancer cell growth.
Chen R; Zhou S; Fang C; Ye F; Chen J; Jiang P
Histol Histopathol; 2022 Apr; 37(4):397-404. PubMed ID: 34951005
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous silencing Aurora-A and UHRF1 inhibits colorectal cancer cell growth through regulating expression of DNMT1 and STAT1.
Han J; Chen X; Xu J; Chu L; Li R; Sun N; Jiang Z; Liu H; Ge X; Zheng J; Yang J; Ikezoe T
Int J Med Sci; 2021; 18(15):3437-3451. PubMed ID: 34522170
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Disseminated Pluripotent Tumor Cell Signature Expression in the Bone Marrow from Patients with Colorectal Cancer.
Gasser M; Kim M; Rehder R; Frank N; Frank M; Grimmig T; Moench R; Ribas C; Illert B; Germer CT; Rosenwald A; Waaga-Gasser AM
J Cancer Sci Ther; 2017; 9(10):669-674. PubMed ID: 34221246
[TBL] [Abstract][Full Text] [Related]
16. Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance.
Jalalirad M; Haddad TC; Salisbury JL; Radisky D; Zhang M; Schroeder M; Tuma A; Leof E; Carter JM; Degnim AC; Boughey JC; Sarkaria J; Yu J; Wang L; Liu MC; Zammataro L; Malatino L; Galanis E; Ingle JN; Goetz MP; D'Assoro AB
Oncogene; 2021 Apr; 40(14):2509-2523. PubMed ID: 33674749
[TBL] [Abstract][Full Text] [Related]
17. Adaptive response of resistant cancer cells to chemotherapy.
Chern YJ; Tai IT
Cancer Biol Med; 2020 Nov; 17(4):842-863. PubMed ID: 33299639
[TBL] [Abstract][Full Text] [Related]
18. The role of Aurora-A in human cancers and future therapeutics.
Lin X; Xiang X; Hao L; Wang T; Lai Y; Abudoureyimu M; Zhou H; Feng B; Chu X; Wang R
Am J Cancer Res; 2020; 10(9):2705-2729. PubMed ID: 33042612
[TBL] [Abstract][Full Text] [Related]
19. The New Paradigm of Network Medicine to Analyze Breast Cancer Phenotypes.
Grimaldi AM; Conte F; Pane K; Fiscon G; Mirabelli P; Baselice S; Giannatiempo R; Messina F; Franzese M; Salvatore M; Paci P; Incoronato M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932728
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
